Sponsor or institution
Clinical trials and research at Shanghai Jiatan Pharmatech Co., Ltd
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Shanghai Jiatan Pharmatech Co., Ltd that are recruiting, in China. By phase: Phase 1 (1), Phase 1/2 (1), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating the pharmacokinetics of Sudapyridine in healthy Chinese males | Phase 1 | Suzhou, Jiangsu | Recruiting | Nov 22, 2024 |
| Combining WX390 and Toripalimab for Advanced Gastric-type Endocervical Adenocarcinoma with STK11 Mutations | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 9, 2023 |
| Combining WX390 and Toripalimab for advanced solid tumors | Phase 1/2 | Changchun, Jilin | Recruiting | Nov 7, 2023 |
| Oral Sudapyridine for treating rifampicin-resistant pulmonary tuberculosis | Phase 3 | Beijing, Beijing Municipality and 1 other locations | Recruiting | Apr 24, 2023 |
All recruiting trials (4)
-
Evaluating the pharmacokinetics of Sudapyridine in healthy Chinese males
This study is testing how the body processes a new drug called Sudapyridine in healthy Chinese men after they take a single dose.
-
Combining WX390 and Toripalimab for Advanced Gastric-type Endocervical Adenocarcinoma with STK11 Mutations
This study is testing if a new combination of medications, WX390 and Toripalimab, can help people with advanced Gastric-type Endocervical Adenocarcinoma that has STK11 mutations.
-
Combining WX390 and Toripalimab for advanced solid tumors
This study is testing if a new combination of two drugs, WX390 and Toripalimab, can safely help people with advanced solid tumors.
-
Oral Sudapyridine for treating rifampicin-resistant pulmonary tuberculosis
This study is testing if a new medication called Sudapyridine can help people with rifampicin-resistant pulmonary tuberculosis get better compared to another treatment called bedaquiline.
Quick answers
How many clinical trials run by Shanghai Jiatan Pharmatech Co., Ltd are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.